Pediatrics News and Research

Latest Pediatrics News and Research

Listeriosis and pregnancy

For years, doctors have puzzled over why pregnant women are 20 times more likely than others to be infected by the bacterium Listeria monocytogenes. Researchers at the University of California, Berkeley, now think they have the answer, and it isn't pretty.

3 Jul 2006

Drinking alcohol early in life increases alcohol dependence throughout life

Individuals who are younger when they begin drinking alcohol may face a higher risk of alcohol dependence throughout life, at a younger age and consisting of multiple episodes.

3 Jul 2006

Potential permanent genetic cure for hemophilia A

A discovery by Medical College of Wisconsin and BloodCenter of Wisconsin researchers in Milwaukee may be a key to a permanent genetic cure for hemophilia A patients, including a subset who do not respond to conventional blood transfusions.

3 Jul 2006

Why does prolonged IV feeding damage the liver?

Children who cannot eat on their own because of intestinal failure must rely on parenteral nutrition (PN), an intravenous method of feeding.

3 Jul 2006

Being "at risk for overweight" really means kids are too fat or obese

Obesity appears to be a problem worldwide affecting millions of people in many developed countries.

3 Jul 2006

FDA gives tentative approval for generic pediatric AIDS drug

The Food and Drug Administration (FDA) today announced the tentative approval of the generic version of Abacavir Sulfate Oral Solution.

27 Jun 2006

Full thickness skin grafts for complex penile surgeries in children

Chordee and hypospadias are notorious for having a paucity of penile skin from prior surgical interventions.

26 Jun 2006

FDA approves Prezista (darunavir)

FDA approves Prezista (darunavir), a new drug for adults whose infection with the human immunodeficiency virus (HIV) has not responded to treatment with other antiretroviral drugs.

26 Jun 2006

Safe for cystic fibrosis patients to stop using inhaled corticosteroids

In comparison to cystic fibrosis (CF) patients who regularly use inhaled corticosteroid, those who did not use these drugs for six months exhibited no positive or negative effects in terms of major disease factors.

18 Jun 2006

Discovery of gene behind iron accumulation in brain has implications for Parkinson's, Alzheimer's

Oregon Health & Science University researchers have identified the gene behind a group of rare, progressive childhood disorders caused by an abnormal buildup of iron in the brain.

18 Jun 2006

Exposure to airborne fungal spores increase kids' risk for multiple allergies

University of Cincinnati (UC) researchers say exposure to a certain group of fungal spores - abundant in the air that we breathe every day - can make young children more susceptible to developing multiple allergies later in life.

14 Jun 2006

FDA approves Wellbutrin X for treatment of seasonal depression

The Food and Drug Administration (FDA) has approved Wellbutrin XL for prevention of major depressive episodes in patients with a history of seasonal affective disorder (SAD).

13 Jun 2006

Antipsychotic use in children increasing

A steadily increasing number of patients younger than age 20 received prescriptions for antipsychotic medications between 1993 and 2002, according to a report published in the June issue of Archives of General Psychiatry.

9 Jun 2006

"Mechanistic basis for understanding why we treat symptoms"

In the 1990s, the notion of "six degrees of separation" emphasized human linkages that connected people around the world.

9 Jun 2006

Markey Cancer Center receives approval to test cancer drug DB-67

Tom Burke died of colon cancer only a few years ago, but not before he helped create a new drug to fight cancer.

8 Jun 2006

Popular hypertension drugs triple the risk of birth defects

A study by American researchers has found that certain widely used hypertension drugs, once considered safe in the early stages of pregnancy, can almost triple the risk of birth defects.

8 Jun 2006

Long-term benefits of imatinib for patients newly diagnosed with chronic myelogenous leukemia

The overall survival of most people with chronic myelogenous leukemia (CML) treated with imatinib (Gleevec, STI-571) is extremely high and the relapse rate is quite low, according to new data from a study out of the Oregon Health & Science University Cancer Institute.

6 Jun 2006